Ostic Pharma Pvt Ltd
Ostic Pharma Pvt Ltd is a startup incubated by SINE at IIT Bombay, dedicated to developing affordable healthcare technologies and products. The company is FDA and CDSCO approved, focusing on innovation in medical diagnostics, including rapid COVID-19 tests, molecular diagnostics, and CRISPR-based tests. They aim to improve global health through frugal innovations, offering services in R&D, prototyping, manufacturing, and scaling up diagnostic kits. Their mission is to create a healthier world by promoting unmet needs in healthcare with a focus on vulnerable populations.
Industries
Nr. of Employees
small (1-50)
Ostic Pharma Pvt Ltd
Ostic Pharma Pvt Ltd, 321, Monash Building, IIT Bombay, Powai, Mumbai 400076
Products
Rapid antigen diagnostic kit for SARS-CoV-2
A marketed rapid antigen test for SARS-CoV-2 intended for point-of-care use.
Rapid tuberculosis (TB) diagnostic (lateral flow format)
Rapid point-of-care TB diagnostic under development and in pipeline; described as a lateral flow test with short time-to-result.
Sickle cell screening assay
A diagnostic test developed for screening sickle cell disease (technology transfer and grants referenced for development).
Combo tests for vector-borne diseases
Multiplex/combination rapid tests intended to detect multiple vector-borne pathogens in a single panel.
ELISA and laboratory diagnostic assays
Laboratory-format immunoassays (ELISA) and related analytical diagnostics developed or offered as part of the product portfolio.
Rapid antigen diagnostic kit for SARS-CoV-2
A marketed rapid antigen test for SARS-CoV-2 intended for point-of-care use.
Rapid tuberculosis (TB) diagnostic (lateral flow format)
Rapid point-of-care TB diagnostic under development and in pipeline; described as a lateral flow test with short time-to-result.
Sickle cell screening assay
A diagnostic test developed for screening sickle cell disease (technology transfer and grants referenced for development).
Combo tests for vector-borne diseases
Multiplex/combination rapid tests intended to detect multiple vector-borne pathogens in a single panel.
ELISA and laboratory diagnostic assays
Laboratory-format immunoassays (ELISA) and related analytical diagnostics developed or offered as part of the product portfolio.
Services
Contract R&D for development of in vitro diagnostics including assay development, prototype testing, validation support and regulatory guidance for external clients.
End-to-end services from rapid prototyping to pilot manufacturing and scale-up for diagnostic devices, including batch production for external validation.
Contract R&D for development of in vitro diagnostics including assay development, prototype testing, validation support and regulatory guidance for external clients.
End-to-end services from rapid prototyping to pilot manufacturing and scale-up for diagnostic devices, including batch production for external validation.
Expertise Areas
- In vitro diagnostic (IVD) development
- Lateral flow assay development and manufacturing
- Molecular and CRISPR-based diagnostics
- Diagnostic manufacturing scale-up and prototyping
Key Technologies
- Lateral flow immunoassays (LFAs)
- Molecular diagnostics (nucleic-acid based assays)
- CRISPR-based detection assays
- Next-generation sequencing (NGS)
News & Updates
Startup Award by Honble VC, SKOUST and Shri Rohit Kansal
Recognized for outstanding contribution to the fight against Covid pandemic, developed Rapid COVID Diagnostics, and donated over 10,000 RATs.
Top 10 winners under Dialogue on Role of Innovations in Disaster Risk Reduction (DRR) & SARTHI Awards
Awarded for contribution in Covid Pandemic.
Startup Award by Honble VC, SKOUST and Shri Rohit Kansal
Recognized for outstanding contribution to the fight against Covid pandemic, developed Rapid COVID Diagnostics, and donated over 10,000 RATs.
Top 10 winners under Dialogue on Role of Innovations in Disaster Risk Reduction (DRR) & SARTHI Awards
Awarded for contribution in Covid Pandemic.